Načítá se...
Assessing treatment efficacy in the subset of responders in a randomized clinical trial
BACKGROUND: Durability of response is a clinically relevant dimension of the treatment effect in randomized clinical trials; it is often measured by comparing among the responders the duration of response between the treatment arms. However, since the comparison groups are defined by response (a pos...
Uloženo v:
| Vydáno v: | Ann Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834152/ https://ncbi.nlm.nih.gov/pubmed/28444115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx197 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|